Kumar Amber, Singh Akash Ranjan, Anand Praveen, Pandey Dhruvendra, Gupta Sarika, K Lalitha, Puri Inder, Gosh BrajRaj S, Chalga Manjeet Singh, Singh Manjula
Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Bhopal, Madhya Pradesh, India.
Department of Community Medicine, GMC, Shahdol, Madhya Pradesh, India.
Indian J Pediatr. 2025 Feb 3. doi: 10.1007/s12098-024-05364-y.
To assesses the coverage, adherence, reasons for non-initiation and non-completion of tuberculosis preventive treatment (TPT) among household child contacts (HHCC) of pulmonary tuberculosis (TB).
This cross-sectional study was conducted across eight sites in India. Estimated sample size was 200 per site. Information was collected through record review and house-to-house visits of HHCCs of notified pulmonary TB cases during January to March 2022. Coverage and adherence was assessed by proportion of eligible HHCC initiated and completed TPT, respectively.
Of 2554 HHCCs eligible for TPT, initiation and completion rate was 34% and 22%, respectively. Across the sites the median time to conduct home visit was 14 d (IQR 9, 22) and TPT initiation was 7 d (IQR 1, 21). Reasons for the non-initiation were no information provided by paramedical workers (82%), information provided by paramedical workers but TPT was not given (19%), parents felt it's not important (9%), and fear of side-effects (3%). Reasons for non-completion were: TPT received for less than six months (from healthcare providers) (54%), advised for the lesser duration TPT by the doctors (4%), parents felt completion was not important (32%), parents' fear of side-effects or myth (5%), and HHCC complained of side-effect (0.7%).
Inadequate emphasis on home visits leads to TPT initiation in only one-third and completion in less than one-fourth of eligible HHCCs. This poor coverage was primarily due to the health system related issues. Rarely reported TPT side-effects highlighted its safety.
评估肺结核家庭儿童接触者(HHCC)中结核病预防性治疗(TPT)的覆盖情况、依从性、未开始治疗和未完成治疗的原因。
这项横断面研究在印度的八个地点进行。每个地点的估计样本量为200。通过记录审查和在2022年1月至3月期间对已通报肺结核病例的HHCC进行逐户走访来收集信息。覆盖情况和依从性分别通过开始和完成TPT的合格HHCC比例进行评估。
在2554名 eligible for TPT的HHCC中,开始治疗率和完成治疗率分别为34%和22%。在各个地点,进行家访的中位时间为14天(四分位间距9,22),开始TPT的时间为7天(四分位间距1,21)。未开始治疗的原因是医护人员未提供信息(82%)、医护人员提供了信息但未给予TPT(19%)、家长认为不重要(9%)以及担心副作用(3%)。未完成治疗的原因是:从医疗服务提供者处接受TPT的时间少于六个月(54%)、医生建议的TPT疗程较短(4%)、家长认为完成治疗不重要(32%)、家长担心副作用或误解(5%)以及HHCC抱怨有副作用(0.7%)。
对家访的重视不足导致只有三分之一的合格HHCC开始TPT治疗,不到四分之一的合格HHCC完成治疗。这种低覆盖率主要是由于与卫生系统相关的问题。很少报告的TPT副作用凸显了其安全性。